JP Morgan Chase’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.03M | Sell |
304,894
-91,123
| -23% | -$703K | ﹤0.01% | 4088 |
|
|
2025
Q4 | $3.49M | Buy |
396,017
+196,124
| +98% | +$1.08M | ﹤0.01% | 3641 |
|
|
2025
Q3 | $997K | Buy |
199,893
+28,238
| +16% | +$131K | ﹤0.01% | 4602 |
|
|
2025
Q2 | $810K | Sell |
171,655
-178,946
| -51% | -$782K | ﹤0.01% | 4514 |
|
|
2025
Q1 | $1.61M | Buy |
350,601
+14,860
| +4% | +$69.3K | ﹤0.01% | 4023 |
|
|
2024
Q4 | $1.61M | Buy |
335,741
+175,019
| +109% | +$840K | ﹤0.01% | 4310 |
|
|
2024
Q3 | $754K | Buy |
160,722
+22,249
| +16% | +$119K | ﹤0.01% | 4646 |
|
|
2024
Q2 | $782K | Sell |
138,473
-142,310
| -51% | -$735K | ﹤0.01% | 4423 |
|
|
2024
Q1 | $1.15M | Buy |
280,783
+74,752
| +36% | +$299K | ﹤0.01% | 4239 |
|
|
2023
Q4 | $869K | Sell |
206,031
-21,234
| -9% | -$85.7K | ﹤0.01% | 4422 |
|
|
2023
Q3 | $982K | Buy |
227,265
+95,615
| +73% | +$531K | ﹤0.01% | 4077 |
|
|
2023
Q2 | $868K | Sell |
131,650
-76,222
| -37% | -$489K | ﹤0.01% | 4167 |
|
|
2023
Q1 | $1.41M | Sell |
207,872
-13,412
| -6% | -$94.3K | ﹤0.01% | 3798 |
|
|
2022
Q4 | $1.64M | Buy |
221,284
+74,323
| +51% | +$724K | ﹤0.01% | 3708 |
|
|
2022
Q3 | $1.45M | Buy |
146,961
+41,849
| +40% | +$442K | ﹤0.01% | 3734 |
|
|
2022
Q2 | $1.15M | Sell |
105,112
-258,656
| -71% | -$2.68M | ﹤0.01% | 3975 |
|
|
2022
Q1 | $4.11M | Buy |
363,768
+16,716
| +5% | +$220K | ﹤0.01% | 3173 |
|
|
2021
Q4 | $5.44M | Sell |
347,052
-2,938
| -0.8% | -$51.2K | ﹤0.01% | 2982 |
|
|
2021
Q3 | $6M | Sell |
349,990
-23,841
| -6% | -$418K | ﹤0.01% | 2890 |
|
|
2021
Q2 | $8.04M | Buy |
373,831
+74,483
| +25% | +$1.33M | ﹤0.01% | 2624 |
|
|
2021
Q1 | $4.5M | Sell |
299,348
-66,689
| -18% | -$1.08M | ﹤0.01% | 3061 |
|
|
2020
Q4 | $4.81M | Buy |
366,037
+225,435
| +160% | +$2.71M | ﹤0.01% | 2842 |
|
|
2020
Q3 | $1.34M | Sell |
140,602
-10,744
| -7% | -$115K | ﹤0.01% | 3482 |
|
|
2020
Q2 | $1.73M | Sell |
151,346
-20,846
| -12% | -$236K | ﹤0.01% | 3197 |
|
|
2020
Q1 | $1.78M | Sell |
172,192
-17,156
| -9% | -$213K | ﹤0.01% | 3054 |
|
|
2019
Q4 | $3.11M | Sell |
189,348
-13,977
| -7% | -$211K | ﹤0.01% | 3063 |
|
|
2019
Q3 | $2.7M | Sell |
203,325
-97,602
| -32% | -$1.36M | ﹤0.01% | 3209 |
|
|
2019
Q2 | $4.34M | Buy |
300,927
+99,602
| +49% | +$1.59M | ﹤0.01% | 2752 |
|
|
2019
Q1 | $3.71M | Sell |
201,325
-32,403
| -14% | -$738K | ﹤0.01% | 2846 |
|
|
2018
Q4 | $6.11M | Sell |
233,728
-57,367
| -20% | -$1.35M | ﹤0.01% | 2413 |
|
|
2018
Q3 | $6.68M | Sell |
291,095
-19,675
| -6% | -$402K | ﹤0.01% | 2513 |
|
|
2018
Q2 | $5.92M | Buy |
310,770
+21,301
| +7% | +$356K | ﹤0.01% | 2548 |
|
|
2018
Q1 | $4.88M | Sell |
289,469
-90,360
| -24% | -$1.51M | ﹤0.01% | 2595 |
|
|
2017
Q4 | $5.77M | Buy |
379,829
+320,491
| +540% | +$4.76M | ﹤0.01% | 2567 |
|
|
2017
Q3 | $1.07M | Sell |
59,338
-80,835
| -58% | -$1.35M | ﹤0.01% | 3484 |
|
|
2017
Q2 | $2.29M | Sell |
140,173
-1,878
| -1% | -$27.1K | ﹤0.01% | 2961 |
|
|
2017
Q1 | $1.99M | Sell |
142,051
-38,261
| -21% | -$545K | ﹤0.01% | 3045 |
|
|
2016
Q4 | $2.88M | Buy |
180,312
+25,999
| +17% | +$418K | ﹤0.01% | 2849 |
|
|
2016
Q3 | $2.57M | Buy |
154,313
+84,401
| +121% | +$1.14M | ﹤0.01% | 2654 |
|
|
2016
Q2 | $782K | Buy |
69,912
+69,654
| +26,998% | +$675K | ﹤0.01% | 3267 |
|
|
2016
Q1 | $2K | Hold |
258
| – | – | ﹤0.01% | 4515 |
|
|
2015
Q4 | $2K | Buy |
+258
| New | +$2.58K | ﹤0.01% | 4534 |
|
Other funds holding VNDA
ACM
VCM
